Oct 9, 2026Polyphron Raises $20M to Predict Drug Toxicity in Human Tissue Before Clinical Trials
AI can now generate more drug candidates than scientists can test. The hard part is proving which ones work in humans, because animal studies and clinical trials move slowly and carry high costs, while lab shortcuts like cell assays often miss how re...










